Israel - English - Ministry of Health

merck serono ltd - follitropin alfa - powder for solution for injection - follitropin alfa 5.5 mcg/dose - follitropin alfa - follitropin alfa - 1) gonal-f followed by chorionic gonadotrophin (hcg) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf) gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism.

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, powder, for solution - 5.5 mcg/vial - follitropin alfa 75iu (5.5mcg) /vial

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, solution - 22.23 mcg - follitropin alfa 22.23 mcg

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, solution - 33.34 mcg - follitropin alfa 33.34 mcg

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, powder, for solution - 600 iu/ml - follitropin alfa 600 iu/ml

Israel - English - Ministry of Health

merck serono ltd - follitropin alfa - solution for injection - follitropin alfa 600 iu/ml - follitropin alfa - follitropin alfa - in adult women:• anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate.• stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift).• follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult men:• follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, powder, for solution - 450 iu/0.75 ml

Singapore - English - HSA (Health Sciences Authority)

merck pte. ltd. - follitropin alfa - injection, solution - 66.69 mcg - follitropin alfa 66.69 mcg

European Union - English - myHealthbox

finox biotech ag - follitropin alfa - solution for injection in pre-filled pen (injection). - 75 iu/0.125ml - anovulation - sex hormones and modulators of the genital systems - in adult women - anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate. - stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift). - follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l. in adult men - follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

European Union - English - EMA (European Medicines Agency)

gedeon richter plc. - follitropin alfa - anovulation - sex hormones and modulators of the genital system, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.